Heska Corp
NASDAQ:HSKA
Intrinsic Value
Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. [ Read More ]
The intrinsic value of one HSKA stock under the Base Case scenario is 2.67 USD. Compared to the current market price of 119.99 USD, Heska Corp is Overvalued by 98%.
Valuation Backtest
Heska Corp
Run backtest to discover the historical profit from buying and selling HSKA stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Heska Corp
Current Assets | 238.6m |
Cash & Short-Term Investments | 125.2m |
Receivables | 38.4m |
Other Current Assets | 75m |
Non-Current Assets | 354.1m |
Long-Term Investments | 592k |
PP&E | 68.1m |
Intangibles | 211.2m |
Other Non-Current Assets | 74.2m |
Current Liabilities | 42.3m |
Accounts Payable | 12.2m |
Accrued Liabilities | 18.9m |
Other Current Liabilities | 11.1m |
Non-Current Liabilities | 132.7m |
Long-Term Debt | 96m |
Other Non-Current Liabilities | 36.7m |
Earnings Waterfall
Heska Corp
Revenue
|
254.9m
USD
|
Cost of Revenue
|
-145.5m
USD
|
Gross Profit
|
109.4m
USD
|
Operating Expenses
|
-128.7m
USD
|
Operating Income
|
-19.3m
USD
|
Other Expenses
|
-763k
USD
|
Net Income
|
-20m
USD
|
Free Cash Flow Analysis
Heska Corp
What is Free Cash Flow?
HSKA Profitability Score
Profitability Due Diligence
Heska Corp's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
Score
Heska Corp's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
HSKA Solvency Score
Solvency Due Diligence
Heska Corp's solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Score
Heska Corp's solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HSKA Price Targets Summary
Heska Corp
Ownership
HSKA Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
HSKA Price
Heska Corp
Average Annual Return | 31.72% |
Standard Deviation of Annual Returns | 14.99% |
Max Drawdown | -78% |
Market Capitalization | 1.3B USD |
Shares Outstanding | 10 913 800 |
Percentage of Shares Shorted | 16.75% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. The company is headquartered in Loveland, Colorado and currently employs 655 full-time employees. The firm's segments include North America segment includes the contract manufacturing of vaccines and pharmaceutical products, and International consists of geographies outside of North America, primarily its operations in Australia, France, Germany, Italy, Malaysia, Spain and Switzerland. The firm's veterinary instruments include Element RC, Element RCX and Element RC3X. The firm is offerings include Point of Care diagnostic laboratory instruments and consumables; Point of Care digital imaging diagnostic products; reference laboratory testing; digital cytology services; vaccines; local and cloud-based data services; allergy testing and immunotherapy; single-use offerings such as in-clinic diagnostic tests and heartworm preventive products, and practice information management software and related software.
Contact
IPO
Employees
Officers
The intrinsic value of one HSKA stock under the Base Case scenario is 2.67 USD.
Compared to the current market price of 119.99 USD, Heska Corp is Overvalued by 98%.